Ichimata Shojiro, Yoshinaga Tsuneaki, Sato Mitsuto, Katoh Nagaaki, Kametani Fuyuki, Yazaki Masahide, Sekijim Yoshiki, Hata Yukiko, Nishida Naoki
Department of Legal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Int J Mol Sci. 2025 May 8;26(10):4505. doi: 10.3390/ijms26104505.
Amyloid deposition has been reported to localize within thrombi; however, its pathological characteristics, particularly its precursor proteins, remain poorly understood. This study aimed to elucidate the pathological features of thrombus-associated amyloid deposition by immunohistochemistry combined with proteomic analyses using liquid chromatography-tandem mass spectrometry with laser microdissection. Our findings revealed that thrombus-associated amyloid deposits within the thrombus and vessel wall primarily comprised apolipoprotein A-I, with a mixture of amyloid fibrils derived from amyloidogenic proteins, including transthyretin and lactoferrin. Given that these proteins are present in the blood, our results support a previous hypothesis that proteins denatured during thrombus aging are a source of amyloid. Furthermore, phagocytes were infiltrated around the intramural and extravascular deposits rather than around the amyloid deposits within the thrombus. Therefore, amyloid deposits generated within the thrombus may be transported from regions with limited blood flow to the vessel wall and surrounding tissues, where blood flow is present, during thrombus processing. These deposits were primarily removed by phagocytic cells. Our results suggest that a facilitative effect on deposition occurs via a cross-seeding mechanism between amyloid fibrils and that phagocytes can remove amyloid deposits. These findings help elucidate the pathogenesis of localized amyloidosis.
据报道,淀粉样蛋白沉积定位于血栓内;然而,其病理特征,尤其是其前体蛋白,仍知之甚少。本研究旨在通过免疫组织化学结合蛋白质组学分析(使用液相色谱-串联质谱联用激光显微切割技术)来阐明血栓相关淀粉样蛋白沉积的病理特征。我们的研究结果显示,血栓和血管壁内的血栓相关淀粉样蛋白沉积物主要由载脂蛋白A-I组成,伴有源自包括转甲状腺素蛋白和乳铁蛋白在内的淀粉样蛋白生成蛋白的淀粉样纤维混合物。鉴于这些蛋白质存在于血液中,我们的结果支持了之前的一个假设,即血栓老化过程中变性的蛋白质是淀粉样蛋白的一个来源。此外,吞噬细胞浸润在壁内和血管外沉积物周围,而非血栓内的淀粉样蛋白沉积物周围。因此,血栓内产生的淀粉样蛋白沉积物可能在血栓形成过程中从血流受限区域转运至存在血流的血管壁和周围组织。这些沉积物主要由吞噬细胞清除。我们的结果表明,淀粉样纤维之间的交叉成种机制对沉积有促进作用,且吞噬细胞可以清除淀粉样蛋白沉积物。这些发现有助于阐明局限性淀粉样变性的发病机制。